Harjit Gill's most recent trade in Resmed Inc. was a trade of 1,073 ResMed Common Stock done . Disclosure was reported to the exchange on Nov. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ResMed | Harjit Gill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 1,073 | 10,940 (0%) | 0% | 0 | ResMed Common Stock | |
| ResMed | Harjit Gill | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 251.47 per share. | 11 Nov 2025 | 38 | 9,867 (0%) | 0% | 251.5 | 9,556 | ResMed Common Stock |
| ResMed | Harjit Gill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2024 | 1,083 | 9,905 (0%) | 0% | 0 | ResMed Common Stock | |
| ResMed | Harjit Gill | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 253.53 per share. | 11 Nov 2024 | 132 | 8,822 (0%) | 0% | 253.5 | 33,466 | ResMed Common Stock |
| ResMed | Harjit Gill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2023 | 1,768 | 8,955 (0%) | 0% | 0 | ResMed Common Stock | |
| ResMed | Harjit Gill | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 143.96 per share. | 13 Nov 2023 | 79 | 7,187 (0%) | 0% | 144.0 | 11,373 | ResMed Common Stock |
| ResMed | Harjit Gill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2022 | 1,122 | 7,266 (0%) | 0% | 0 | ResMed Common Stock | |
| ResMed | Harjit Gill | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 225.17 per share. | 11 Nov 2022 | 41 | 6,144 (0%) | 0% | 225.2 | 9,232 | ResMed Common Stock |
| ResMed | Harjit Gill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2021 | 956 | 6,185 (0%) | 0% | 0 | ResMed Common Stock |